tirzepatide and trt together CME INDIA on X: "“Tirzepatide Shown to Tackle Hypogonadism” from ENDO 2025: 📰 CME INDIA – Clinical Pearls: in Obesity-Associated Hypogonadism @Rssdi_official @IndiaESI @AskDrShashank @banshisaboo @DrAmbrishMithal @dramitaol @KapoorNitinDr Tirzepatide and Testosterone | MVP

Legislative changes that remove the current exemption allowing community pharmacists to compound GLP-1 RAs set a concerning precedent, and fail to address the problem at hand

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown promising effects on heart failure (HF) outcomes, particularly in phenotype-specific populations

The depletion of this antioxidant has been correlated with lower immune function and increased vulnerability to infection due to the liver's reduced ability to detoxify

Improvements in lipid profiles further enhance cardiovascular protection

Roughly three-quarters of each group 77% of compounded users and 74% of brand-name users report that the medicine is either effective or extremely effective. One-Third of Compounded GLP-1 Users Have Switched From Brand Name While reported effectiveness is similar between brand-name and compounded or custom-mixed users, the latter variety appears to be gaining momentum in the marketplace